NCT06697223Phase 2Completed

A Study to Assess Recovery and Survival of Radiolabeled Apheresis Platelet Components Treated With the INTERCEPT Blood System for Platelets With LED Illuminator.

Study sponsor: Cerus Corporation

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2025-06-02Actual
Enrollment · participants40Actual
Source updated2026-08-04Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 1 field changed

Main study measure wording changed

Text changed; whether the study measures changed has not been verified. Saved text may be shortened.

Before: Measure: Post infusion recovery of Test platelets at end of 5 day storage Measure: Post infusion survival of Test platelets at end of 5 Day storage. After: Measure: Post Infusion Recovery of Test Platelets at End of 5 Day Storage Measure: Post Infusion Survival of Test Platelets at End of 5 Day Storage.

Check registry source

· 5 fields changed

Participant count type changed

Before: Estimated. After: Actual.

Enrollment · participant count changed

Before: 60 participants (planned). After: 40 participants (actual).

Completion date type changed

Before: Estimated. After: Actual.

Primary completion date changed

Before: Oct 2025. After: 2 Jun 2025.

Recruitment status changed

Before: Not yet recruiting. After: Completed.

Check registry source

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview